Nabsys

We’re excited to share that Nabsys has been shortlisted for Citeline’s Technology Innovation of the Year award! 🎉 This recognition highlights the innovation driving our work to advance genomic analysis. We’re proud to be among this year’s shortlisted companies and grateful to everyone helping move the field forward. Learn more about the shortlist: hubs.ly/Q04CwF8S0 #EGM #Genomics #Innovation #CitelineAwards

Expansions spanning hundreds or thousands of repeats can be difficult to characterize. Current methods can struggle to detect long repeat regions, and preferential amplification of shorter alleles can distort the picture. Detecting an expansion does not always mean resolving its size. By analyzing long DNA molecules, RepX avoids amplification bias and delivers single-molecule data up to 23 loci associated with genetic diseases, enabling insights into repeat instability and heterogeneity that other techniques miss. Interested? Download the FXN tech note to learn how RepX can deliver insights that go beyond the ordinary. 👉 hubs.ly/Q04Cd6wF0 #RepeatExpansions #EGM #RepX

That’s a wrap on ASHG 2026! 🧬  Thank you to everyone who stopped by Nabsys Booth #501, attended our CoLab presentation, visited our posters, and took the time to learn more about Electronic Genome Mapping. And thank you to the ASHG community for the conversations, questions, collaborations. We’re heading home inspired by the research being done across the genomics community and excited for what’s next for EGM! #ASHG26 #ElectronicGenomeMapping #EGM #StructuralVariation #Hememalignancies

🧬 Nabsys will be at the 2026 Long-Read Sequencing Symposium! Join us at the Brotman Baty Institute’s symposium to connect with the genomics research community and learn how Electronic Genome Mapping (EGM) on the OhmX™ Platform provides high-resolution insights into genome structure. 📍 Stop by the Nabsys table to meet our team and learn more about our technology! We look forward to connecting with you. #ElectronicGenomeMapping #EGM #LongReadSequencing

We’re ending #ASHG26 with a bang! 🧬 We're highlighting three posters showcasing new research and applications of Electronic Genome Mapping across structural variation, CRISPR/Cas9 optimization, constitutional genomics, and leukemia-associated variants. 🔬 Poster #5008F: Reviewers’ Choice Poster CRISPR/Cas9 Optimization by Electronic Genome Mapping 🔬 Poster #2025F: Assessment of Structural and Copy Number Variants in Constitutional Samples Using Electronic Genome Mapping 🔬 Poster #8133F: Detection of Leukemia-Associated Structural Variants Using Electronic Genome Mapping Technology We’re excited to share this breadth of EGM research with the genomics community. Stop by the posters to connect with our scientists and collaborators and visit Booth #501 if you haven’t already! #ASHG #ElectronicGenomeMapping #EGM #StructuralVariation #CRISPR

Nabsys is presenting two posters today at #ASHG26, exploring new applications of Electronic Genome Mapping (EGM) in genomic research. 🧬 🔬 Poster #8146T: Genome-Scale Mapping of Human LINE-1 ORF2p Endonuclease Activity presented by Michael Gallagher, PhD, Software Applications Scientist, Nabsys 🧬 Poster #2031T: CRISPR-Assisted Electronic Genome Mapping for Robertsonian Translocations and FSHD presented by Erika Headrick, MS, Software Product Manager, Nabsys Both posters are being presented today, Thursday, October 22, from 4:15–6:15 PM EDT. Stop by to explore the research and connect with our team at #ASHG26! #ASHG #ElectronicGenomeMapping #EGM #CRISPR #StructuralVariation #FSHD

Join us today at CoLab Theater #1 as Alka Chaubey, PhD, FACMG, our Chief Medical and Genomics Officer presents: “Electronic Genome Mapping in Hematologic Malignancies: Bridging Cytogenetics and Molecular Genomics” 📅 Thursday, October 22 ⏰ 5:00–5:30 PM 📍 CoLab Theater #1 The presentation will highlight how EGM provides a high-resolution, genome-wide view of structural variation, complementing cytogenetic and molecular genomic approaches and helping characterize complex genomic events. If you’re at #ASHG, add it to your schedule and stop by Booth #501 to continue the conversation with the Nabsys team. #ASHG26 #EGM #StructuralVariation #Hememalignancies

We’re excited to kick off #ASHG26 with a poster presentation titled CRISPR/Cas9 Customization of Electronic Genome Mapping Repeat Expansion Assays! 🧬 The work highlights how CRISPR/Cas9 customization can expand the application of EGM for investigating repeat expansions and complex genomic regions. Stop by Poster #8132W to learn more and connect with Kasra, or visit Nabsys at Booth #501 throughout ASHG. #ASHG #ElectronicGenomeMapping #EGM #RepeatExpansions #CRISPR

🧬 One talk you won’t want to miss at #ASHG26. What can Electronic Genome Mapping reveal in hematologic malignancies? Find out Thursday as our Chief Medical and Genomics officer, Alka Chaubey, PhD, FACMG, takes the stage to share new data on EGM and structural variation. 📍 CoLab Theater #1 ⏰ 5:00–5:30 PM See you there! #ASHG2026 #ElectronicGenomeMapping #EGM #HematologicMalignancies

Visit the Nabsys booth for a live demonstration of Nabsys Navigator™ and see how researchers can: ✔ View analyzed genome mapping data in minutes ✔ Visualize structural variants with intuitive tools ✔ Generate clear, shareable reports ✔ Work within a platform that's simple, secure, affordable, and fast Whether you're exploring complex genomes or verifying known variants, we'll show you how Nabsys Navigator helps turn genomic data into meaningful insights. 📍 Visit us at Booth #501 👉 Schedule your personalized demo today: hubs.ly/Q04zFJjJ0 #ASHG26 #StructuralVariants #GenomeAnalysis

🚀 We just launched RepX™ for repeat expansion analysis! Available through the Nabsys Navigator™ cloud platform, RepX offers the potential to analyze up to 23 disease-associated repeat expansion loci in a single, low-cost run using Electronic Genome Mapping (EGM). We’ll be demonstrating RepX at our ASHG 2026 booth #501 in Montréal. Stop by to learn more! 🔗 Read the full announcement: hubs.ly/Q04BrBk80 #ElectronicGenomeMapping #EGM #ASHG26 #RepX

🚨 We’re excited to announce our collaboration with Augusta University Medical College of Georgia, with four OhmX instruments now in place to evaluate EGM in hematologic malignancies. "Our experience with genome mapping has shown us how much more there is to learn about the structural complexity of the genome. Building on our initial findings with electronic genome mapping, we are excited to bring the Nabsys OhmX system into our laboratory to deepen our understanding of the genomic alterations that drive human disease." - Dr. Kolhe Special thanks to Dr. Ashis Mondal and Dr. Vishakha Vashistha for their contributions and efforts in bringing this technology into our laboratory as well as everyone at Nabsys who helped make this milestone possible! #OhmX #EGM #GenomeResearch #StructuralVariation

Nabsys is heading to ASHG 2026 in Montreal! Join us to see how Electronic Genome Mapping (EGM) is making high-resolution structural variant analysis more accessible, and learn about our latest research in hematologic malignancies, repeat expansions, and SV confirmation. 📍Visit us at Booth #501 🧬 Stop by our six posters 🗣️ Attend our CoLab “Electronic Genome Mapping in Hematologic Malignancies: Bridging Cytogenetics and Molecular Genomics” Oct. 22 at 5PM presented by Brynn Levy, PhD, MSc, Columbia University 👉 See all the happening here: hubs.ly/Q04zG6Pt0 Interested in learning more? Book a meeting with us! hubs.ly/Q04zG6LQ0 #ASHG26 #ElectronicGenomeMapping #EGM #StructuralVariation #Hememalignancies

We’re thrilled to release RepX repeat expansion analysis pipeline on Nabsys Navigator today! RepX brings repeat expansion analysis into the Navigator analytics environment, joining our de novo assembly (SV-Discover™) and targeted variant calling (SV-Verify™) solutions currently available for the OhmX platform. Why RepX? It analyzes electronic genome mapping (EGM) data to estimate repeat lengths from individual DNA molecules without the need for DNA amplification or target enrichment. In a single run, researchers can size repeat expansions such as FMR1, FXN, C9orf72, DMPK, and 19 other loci. If you’re currently doing confirmation and/or screening for repeat expansions using PCR, let’s chat about how RepX can change the narrative. 👉 Learn more: hubs.ly/Q04B3yb00 #RepX #RepeatExpansions #ElectronicGenomeMapping #EGM

🇫🇷 Nabsys was proud to sponsor the recent meeting of the French-Speaking Group for Cellular Hematology (GFHC), bringing together experts advancing genomic technologies and cytogenetics across the region. It was especially exciting to have Dana present in France for the first time, sharing how Electronic Genome Mapping (EGM) can bring new capabilities to genomic research. Thank you to the organizers and everyone who joined us for the thoughtful questions, discussion, and enthusiasm around what’s next in genomic analysis. #ElectronicGenomeMapping #EGM #Cytogenetics #Hematology #GenomicResearch

In Augusta University’s proof-of-principle study of five AML and CML bone marrow samples, EGM detected structural and copy-number changes spanning translocations, whole-chromosome gains and losses, segmental copy-number loss, and complex rearrangements. EGM was also concordant with all nine OGM calls in the study. Among the findings was a ~8 kb insertion within KMT2A, demonstrating the range of genomic events captured by EGM. All from a genome-wide approach using electronic detection designed for high resolution, reduced platform size, and lower costs. 👉 Read the preprint: hubs.ly/Q04yrN550 #EGM #hememalignancies

🧬 We’re excited to sponsor the New York State Cytogenetics event hosted by Roswell Park and connect with researchers and cytogenetics professionals working to advance genome analysis. Our team will be onsite with a table to share more about Nabsys’ Electronic Genome Mapping (EGM) technology and the OhmX Platform. 👉 Interested in learning more? Book a meeting with us! hubs.ly/Q04z3sZl0 #EGM #Cytogenetics #GenomeMapping #StructuralVariation

October is Breast Cancer Awareness Month where we recognize the importance of research, collaboration, and continued discovery.🎗️ At Nabsys, we’re proud to support the research community and the scientists working to expand what we know about the genome and its role in cancer. Together, we can keep the conversation going and continue working toward a future where fewer lives are impacted by breast cancer. #BreastCancerAwarenessMonth #BreastCancerResearch #ResearchIsTheReason #BCRF

Research moves faster when your analysis platform keeps up. Nabsys Navigator™ brings discovery and verification together in one workspace with applications including: 🧬 SV-Discover™ for genome-wide structural variant detection. ✅ SV-Verify™ for targeted verification of known or suspected variants. Plus specialized workflows for: - Orthogonal confirmation of NGS data - Repeat expansion analysis - Copy number analysis One platform. Multiple applications. Faster answers. 👉 Explore the full suite: hubs.ly/Q04y8Qwn0 #StructuralVariants #GenomeAnalysis #ResearchTools

In a proof-of-principle study of five AML and CML bone marrow samples, EGM was concordant with all six abnormalities identified by karyotyping and FISH. We’re particularly excited about what EGM found beyond just the concordance. In a complex AML sample, EGM further characterized a 20q loss as an intrachromosomal fusion and identified a 7q22.1 copy-number loss not reported by karyotyping or FISH. Concordance plus additional structural and copy-number information is what makes these early results compelling. 👉 Learn more about EGM for hematologic malignancy research: hubs.ly/Q04ywWBV0 #EGM #hememalignancies